Evidence map›Paper›PMID 34046099›Full record

ReviewWorld journal of oncology2021

Personalized Medicine in Oncology in the Developing World: Barriers and Concepts to Improve

Adeoluwa Akeem Adeniji, Soniya Dulal, Mike G Martin

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Liquid Biopsy in Solid Tumours: An Overview.Cytopathology : official journal of the British Society for Clinical Cytology · 2025
    Review
  5. Review
  6. Article
  7. Opportunities for promoting open data in the Caribbean through biobanks.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Precision Medicine in Type 1 Diabetes.Journal of the Indian Institute of Science · 2023
    Review
  15. Types of Cancer and Research Covered inWorld journal of oncology · 2022
    Article
  16. Fighting Cancer around the World: A Framework for Action.Healthcare (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Highlights fromEcancermedicalscience · 2022
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Adeoluwa Akeem AdenijiOncology and Radiotherapy Department, Lagos University Teaching Hospital, Lagos, Nigeria.
Soniya DulalNational Academy of Medical Sciences (NAMS), Bir Hospital, Kathmandu, Nepal.
Mike G MartinWest Cancer Centre and Research Institute, Memphis, TN, USA.
Bir Hospital · NPLagos University Teaching Hospital · NGWest Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Personalized medicine (PM) has revolutionized oncology management in high human development indexed countries. By interrogating both disease and host factors through a variety of tools, oncologists have been able to better target an individual's cancer, leading to improved outcomes. But both the tools used to define these variables, such as next generation sequencing, large immunohistochemical and fluorescence

Indexed as

BarriersCost-efficacyDeveloping worldIndividualized patient profilingOncologyPatient stratificationPersonalized medicine

Identifiers

PMID34046099
PMCPMC8139741
OpenAlexW3160089208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.